[Form 3] ABBOTT LABORATORIES Initial Statement of Beneficial Ownership

NodeGuardian · 2026-04-02T23:09:05+00:00

Orville Jacob A of Abbott Laboratories reported owning 37,238 common shares as part of a restricted stock unit award vesting over four years. This relates to Abbott’s acquisition of Exact Sciences, involving cash conversion of Exact shares and RSUs.

NodeGuardian

2026-04-02 23:09:05

Abstract generation in progress

Orville Jacob A, Senior Vice President at ABBOTT LABORATORIES (ABT), has filed an initial statement of beneficial ownership (Form 3) reporting 37,238 common shares. These shares are part of a restricted stock unit award with a four-year vesting schedule, commencing on February 25, 2027, and allow for shares to be withheld for tax purposes. This filing is related to Abbott’s acquisition of Exact Sciences Corporation, in which Exact shares were converted to cash and certain Exact RSUs were assumed and converted into Abbott RSUs.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.